Inhibition of BRD4 attenuates TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis [17] and BRD4 may act as a Keap1/Nrf2 upstream regulatory target to regulate oxidative stress and myocardial fibrosis. This evidence concerns the gene KEAP1 and Myocardial fibrosis.